Given the potential effects of OPA1 in PFKFB3 overexpression-mediated inhibitory action against DCM, we investigated the underlying mechanisms by which PFKFB3 overexpression upregulates OPA1 expression. This evidence concerns the gene OPA1 and familial dilated cardiomyopathy.